bilirubinometry

bilirubinometry

(bil?i-roo-bin-om'i-tre)
The laboratory technique of measuring bilirubin levels in blood, skin, cerebrospinal fluid, or urine. These measurements are used esp. in the treatment of hyperbilirubinemia in neonates.
See: hyperbilirubinemia; kernicterus
Medical Dictionary, © 2009 Farlex and Partners
References in periodicals archive ?
Transcutaneous bilirubinometry (TCB) is the most widely accepted alternative, as it is reliable and painless7.
(5,6) Transcutaneous spectrophotometric measurement or transcutaneous bilirubinometry is an alternative way of estimating serum bilirubin and is non-invasive, fast, and relatively inexpensive.
Sankar et al., "Reliability of transcutaneous bilirubinometry from shielded skin in neonates receiving phototherapy: A prospective cohort study," Journal of Perinatology, vol.
Blood for total serum bilirubin was taken within 10 minutes of performing transcutaneous bilirubinometry. TSB was estimated by Vanden Berg method.
Study on diagnostic value of transcutaneous bilirubinometry in neonate patients.
The BiliCam "compared favorably" with transcutaneous bilirubinometry, according to the investigators, Dr.
Over the last two decades, transcutaneous bilirubinometry has been developed as a noninvasive, safe, painless, and convenient method for the estimation of total bilirubin level but has not been widely adopted due to concerns about its accuracy.
Transcutaneous bilirubin bilirubinometry measures the amount of bilirubin transferring from serum to the skin tissue.
For decades practitioners have relied on the appearance and intensity of jaundice as a means of deciding when to obtain a TSB measurement, but recognizing that estimating TSB by eye is difficult and on occasion grossly misleading (3) has prompted the development of transcutaneous bilirubinometry.
Transcutaneous bilirubinometry is a noninvasive and cost-effective alternative.
Simple, educated observation and close follow-up has been discredited and usurped by the current recommendation for mass screening of all newborns, regardless of risk factors with transcutaneous bilirubinometry (TcB).